IPSC Financials
Century Therapeutics Inc - Financial statements & key metrics
Stock Price
$2.03
Market Cap
$47.83M
P/E Ratio
-1.3
EPS
$-0.32
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$6.59M
Gross Profit
-
Operating Income
-
Net Income
$-126.57M
EPS (Diluted)
$-1.61
Balance Sheet Highlights
Total Assets
$353.22M
Total Liabilities
$191.85M
Shareholders Equity
-
Cash & Equivalents
$58.44M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-110.14M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-20.0%
Net Margin
-23.4%
ROE
-14.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IPSC revenue?
IPSC's most recent quarterly revenue was $6.59M. Annual revenue can be calculated by summing the four most recent quarters.
Is IPSC profitable?
IPSC reported a loss of $126.57M in the most recent quarter. The net profit margin is -23.4%.
What is IPSC market cap?
IPSC has a market capitalization of $47.83M, making it a small-cap stock.
Does IPSC have debt?
View IPSC's balance sheet for debt information.
What is IPSC cash flow?
Cash flow data is available in the full financial statements.